| Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis A Nagpal, RP Redvers, X Ling, S Ayton, M Fuentes, E Tavancheh, I Diala, ... Breast Cancer Research 21, 1-19, 2019 | 117 | 2019 |
| Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer KA Ung, BA Campbell, D Duplan, D Ball, S David Asia‐Pacific Journal of Clinical Oncology 12 (2), e298-e304, 2016 | 91 | 2016 |
| Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: a prospective clinical trial S David, J Tan, P Savas, M Bressel, D Kelly, F Foroudi, S Loi, S Siva The Breast 49, 55-62, 2020 | 67 | 2020 |
| Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study C Pandeli, LML Smyth, S David, AW See Radiation Oncology 14 (1), 223, 2019 | 60 | 2019 |
| The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification A Cochet, S David, K Moodie, E Drummond, G Dutu, M MacManus, ... Cancer Imaging 14, 1-9, 2014 | 49 | 2014 |
| Safety, efficacy, and patterns of failure after single-fraction stereotactic body radiation therapy (SBRT) for oligometastases P Sogono, M Bressel, S David, M Shaw, S Chander, J Chu, N Plumridge, ... International Journal of Radiation Oncology* Biology* Physics 109 (3), 756-763, 2021 | 24 | 2021 |
| Comparison of magnetic resonance imaging and computed tomography for breast target volume delineation in prone and supine positions EM Pogson, GP Delaney, V Ahern, MM Boxer, C Chan, S David, ... International Journal of Radiation Oncology* Biology* Physics 96 (4), 905-912, 2016 | 24 | 2016 |
| Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: non-consecutive case series and review of the literature S David, G Ho, D Day, M Harris, J Tan, S Goel, GG Hanna, R Srivastava, ... Translational Oncology 14 (1), 100939, 2021 | 23 | 2021 |
| Impact of pretreatment combined 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging on radiation therapy treatment decisions in locally advanced … SP Ng, S David, M Alamgeer, V Ganju International Journal of Radiation Oncology* Biology* Physics 93 (1), 111-117, 2015 | 20 | 2015 |
| Single fraction stereotactic ablative body radiotherapy for oligometastasis: Outcomes from 132 consecutive patients S Gandhidasan, D Ball, T Kron, M Bressel, M Shaw, J Chu, S Chander, ... Clinical Oncology 30 (3), 178-184, 2018 | 18 | 2018 |
| Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR) R Alomran, M White, M Bruce, M Bressel, S Roache, L Karroum, ... BMC cancer 21, 1-9, 2021 | 16 | 2021 |
| Combining radiotherapy and immunotherapy in metastatic breast cancer: Current status and future directions S David, J Tan, S Siva, L Karroum, P Savas, S Loi Biomedicines 10 (4), 821, 2022 | 9 | 2022 |
| SABR in oligometastatic breast cancer: Current status and future directions R Stewart, M White, J Tan, S Siva, L Karroum, S David The Breast 60, 223-229, 2021 | 9 | 2021 |
| Stereotactic ablative body radiotherapy (SABR) for oligoprogressive ER-positive breast cancer (AVATAR): a phase II prospective multicenter trial SP David, S Siva, M Bressel, J Tan, GG Hanna, RK Alomran, E Yip, ... International Journal of Radiation Oncology, Biology, Physics 117 (4), e6, 2023 | 8 | 2023 |
| The impact of imaging modality (CT vs MRI) and patient position (supine vs prone) on tangential whole breast radiation therapy planning K Dundas, EM Pogson, V Batumalai, GP Delaney, MM Boxer, ML Yap, ... Practical radiation oncology 8 (3), e87-e97, 2018 | 7 | 2018 |
| Impact of medical operability and total metastatic ablation on outcomes after SABR for oligometastases S Siva, G Jones, M Bressel, M Shaw, S Chander, J Chu, N Plumridge, ... International Journal of Radiation Oncology* Biology* Physics 114 (5), 862-870, 2022 | 6 | 2022 |
| Abstract PD10-02: A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced … S David, P Savas, S Siva, M White, MW Neeson, S White, G Marx, ... Cancer Research 82 (4_Supplement), PD10-02-PD10-02, 2022 | 5 | 2022 |
| Single‐fraction stereotactic ablative body radiotherapy for sternal metastases in oligometastatic breast cancer: Technique and single institution experience MP Li, D Kelly, J Tan, S Siva, T Kron, S David Journal of Medical Imaging and Radiation Oncology 64 (4), 580-585, 2020 | 4 | 2020 |
| Long-term survival with 18-fluorodeoxyglucose positron emission tomography-directed therapy in non-small cell lung cancer with synchronous solitary brain metastasis S Newman, N Bucknell, M Bressel, P Tran, BA Campbell, S David, ... Clinical Oncology 33 (3), 163-171, 2021 | 2 | 2021 |
| Brachytherapy utilising miniaturised X-ray tubes–clinical implementation and future applications P Ramachandran, D Wanigaratne, J Hagekrykou, K Roozen, M Geso, ... Journal of Physics: Conference Series 1154 (1), 012023, 2019 | 2 | 2019 |
